Sernova Biotherapeutics Inc Sustainability Reports

Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company developing regenerative medicine therapeutics. Its primary asset is the Cell Pouch System, an implantable medical device designed to house therapeutic cells for treating chronic diseases such as type 1 diabetes.

Sector: Manufacturing

Country: Canada

Exchange: Toronto Stock Exchange

LEI: 254900RK2H89BKIZ3967

8 reports from 2016 to 2025

• Sernova Biotherapeutics Inc 2025 Consolidated Financial Statements
• Sernova Biotherapeutics Inc 2024 Consolidated Financial Statements
• Sernova Biotherapeutics Inc 2023 Consolidated Financial Statements
• Sernova Biotherapeutics Inc 2022 Consolidated Financial Statements
• Sernova Biotherapeutics Inc 2020 Consolidated Financial Statements